For a scientific overview of the microbiome, the difference between GLP-1 agonist drugs and microbial approaches to regulating GLP-1, and the role GLP-1 plays in helping to maintain a healthy weight, please refer to the white paper: Harnessing GLP-1 in the digestive tract for better metabolic health
Dose dependent pharmacokinetics of N -acetylcysteine after oral dosing to man
Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: An analysis of two randomized, placebo-controlled trials
Actual costs may be lower with private insurance, Medicare, or savings programs, if prescribed for diabetes, heart, or kidney conditions
No carcinogenicity studies exist
Lilys SURMOUNT-OSA trial will begin in March 2024 to evaluate the effect of Mounjaro on sleep apnea